The Informed Consent Action Network (ICAN) has uncovered a marketing and branding change for one of the developers of “self-spreading vaccines.” Autonomous Therapeutics previously said they develop “artificial immune systems that are inhalable and variant-proof —using a new class of RNA, known as encrypted RNA™.” The company’s website has now updated the front page summary to say they develop “precision medicines that are disease-activated and resistance-proof. We use a new class of RNA, known as encRNA.”

ICAN has been sounding the alarm about the serious potential threat these “inhalable” vaccines pose to the public who would be exposed without knowledge and consent. The organization believes the marketing slogan change is a result of increased attention from the segment that appeared on The HighWire. 

Dr. Ariel Weinberger, the CEO and founder of Autonomous Therapeutics, and Dr. Timothy Notton, the chief scientific officer, co-authored a paper in 2014 making the case for “transmissible antivirals to control population-wide infectious diseases.” They consider transmissible vaccines a way to “therapeutically target the highest-risk populations, circumvent behavioral barriers, and overcome pathogen persistence and resistance mechanisms.”

“Behavioral barriers” refer to the lack of vaccine uptake by members of the public that are deemed to be “vaccine hesitant.” In the aftermath of the COVID-19 pandemic and Operation Warp Speed, there has been a notable increase in vaccine skepticism. That is the basis for the stunning admissions of insufficient safety and efficacy studies by the Godfather of Vaccines, Stanley Plotkin, which was reported by The HighWire earlier this month.

The COVID-19 origin discussion is still in full force, as the Select Subcommittee on the Coronavirus Pandemic has questioned public health officials about the risky gain-of-function research at the Wuhan Institute of Virology, which was a likely source for the virus that sparked the global pandemic. The Highwire interviewed Justin Goodman of the White Coat Waste Project and Biologist Dr. Bryce Nickels about the risks of this research, and they both said the only purpose of doing this laboratory research is to create bio-weapons.

Vaccine hesitancy has increased partly as a result of public health officials trying to cover up the dangerous research in Wuhan. The Defense Advanced Research Projects Agency (DARPA) is responsible for developing technologies for use by the military. DARPA has been funding gain-of-function research on dangerous viruses, and they are also giving millions of dollars to Autonomous Therapeutics to study and bring “inhalable, self-spreading” vaccines to the market.

Autonomous Therapeutics also highlights Dr. Notton’s inclusion on a list of scientists named as “DARPA Risers” during the 60th anniversary of the agency. His work with “inhalable” lipid nanoparticle platforms is also mentioned on his website bio.

The website touts partnerships with DARPA, the Department of Defense, and the NIH. It also lists IQT, as a “top investor in defense and national security startups. IQT mentions its government partnerships on its website. “IQT’s unique approach pairing high-tech problem solvers with government challenges has produced countless impactful solutions for the CIA; DIA; FBI; NGA; NRO; NSA; DHS (including CBP and other DHS components); U.S. Cyber Command; and the U.K. and Australian national intelligence communities. We recently welcomed the Office of Naval Research (ONR), U.S. Central Command, and U.S. Space Force as new government partners and look forward to supporting their missions too.”

Another partnership is Blue Knight, described as “This joint initiative was created between Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. Blue Knight is a collaboration dedicated to anticipating potential health security threats, activating the global innovation community, and amplifying scientific and technological advancements with the aim of preparing for and responding to our rapidly evolving global health environment.”

Several government agencies are involved with pushing this technology forward, and Congress also passed the PREVENT Pandemics Act, which allows the “development and review of new treatments and countermeasures that use cutting-edge, adaptable platform technologies that can be incorporated or used in more than one drug or biological product.”

An ICAN press release from February states, “This Act will also be used to fund a new HHS government agency called ARPA-H (Advanced Research Projects Agency for Health), which was created in 2023 to “take big technical risks that can spark new biomedical breakthroughs” and “revolutionize the detections, diagnosis, mitigation, prevention, treatment and cure of diseases and health conditions.” Both former NIH Director Francis Collins and HHS Secretary Xavier Becerra supported the agency’s creation, and Collins described his vision for ARPA-H as “a DARPA-like culture at NIH.””

Former HHS Director Tevi Troy is on the board for Autonomous Therapeutics and wrote a “guest commentary” article for BioCentury.com arguing that “warp speed isn’t fast enough” and that there is an urgent need for variant-proof therapeutics.

VxBiosciences is the other primary company working on this technology in collaboration with the J. David Gladstone Institutes, led by Leor Weinberger, Ariel’s brother. Leor Weinberger has also conducted studies alongside his brother and “served on the Bill and Melinda Gates Foundation review panel.” Weinberger is currently suing VxBiosciences for breach of contract.

VxBiosciences received $4.8 million from the HHS to develop a “new paradigm for pandemic prevention.” The project description states that the co-evolving, replicating, and self-renewing SARS-COV2 therapies are needed to “circumvent compliance issues.” The therapy will be part of a “co-evolutionary arms race, co-evolving with wild-type virus to overcome resistance.” The innovative therapy would “surmount the universal barriers to pandemic control and lower prevalence for many viruses below levels achievable by vaccination or antiviral therapy campaigns.” The therapy will “utilize superspreaders to deploy the intervention.”

The ICAN attorneys are attempting to gather more information from federal agencies. Through FOIA requests, they have requested information from DARPA, DOI, the Navy, and NIH.

 

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy